Summary by Moomoo AI
On June 18, 2024, WuXi Biologics completed its ninth revision and restatement of its articles of incorporation and bylaws through a special resolution. The revision involves many aspects of the company, including company name, registered office address, company objectives, shareholders' responsibilities, share capital structure, company registration and cancellation, etc. In addition, the revised bylaws also include specific provisions on share transfers, shareholder meetings procedures, board of directors' operations, secretary duties, seal use, accounting and auditing, dividend distribution policies, and other aspects. This revision aims to make the company's articles of incorporation more perfect to meet the current operation requirements and legal requirements.